Results 11 to 20 of about 9,597 (210)

Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2012
Mass vaccinations are a main strategy in the deployment of oral cholera vaccines. Campaigns avoid giving vaccine to pregnant women because of the absence of safety data of the killed whole-cell oral cholera (rBS-WC) vaccine. Balancing this concern is the
Ramadhan Hashim   +24 more
doaj   +4 more sources

Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance [PDF]

open access: yesBMC Public Health, 2009
Background Cholera remains a serious public health problem in low-income countries despite efforts in the past to promote oral rehydration therapy as major treatment.
Chaignat Claire-Lise   +6 more
doaj   +3 more sources

Oral cholera vaccine in cholera prevention and control, Malawi [PDF]

open access: yesBulletin of the World Health Organization, 2018
Problem With limited global supplies of oral cholera vaccine, countries need to identify priority areas for vaccination while longer-term solutions, such as water and sanitation infrastructure, are being developed. Approach In 2017, Malawi integrated oral cholera vaccine into its national cholera control plan. The process started with a desk review and
M’bangombe, Maurice   +16 more
openaire   +4 more sources

An Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, India. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2015
BACKGROUND:Service provider costs for vaccine delivery have been well documented; however, vaccine recipients' costs have drawn less attention. This research explores the private household out-of-pocket and opportunity costs incurred to receive free oral
Vittal Mogasale   +12 more
doaj   +3 more sources

Vaxchora: A Single-Dose Oral Cholera Vaccine [PDF]

open access: yesAnnals of Pharmacotherapy, 2017
Objective: To review trials evaluating the efficacy and safety of Vaxchora, a reformulated, single-dose, oral, lyophilized Vibrio cholerae CVD 103-HgR vaccine for the prevention of travel-related cholera caused by V cholerae serogroup O1. Data Sources: A literature search was conducted using MEDLINE (1946 to January week 3, 2017) and EMBASE (1996 to ...
Adriana, Cabrera   +3 more
openaire   +3 more sources

Review of oral cholera vaccines: efficacy in young children [PDF]

open access: yesInfection and Drug Resistance, 2011
Cristina Masuet Aumatell1, JM Ramon Torrell1, Jane N Zuckerman21International Health Centre, Preventive Medicine Department, Bellvitge Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; 2World Health Organization Collaborating Centre for ...
Masuet Aumatell C   +2 more
doaj   +1 more source

Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study [PDF]

open access: yesThe Lancet Global Health, 2016
Background: Oral cholera vaccines represent a new effective tool to fight cholera and are licensed as two-dose regimens with 2–4 weeks between doses.
Dr. Andrew S Azman, PhD   +24 more
doaj   +3 more sources

Oral Cholera Vaccine Development and Use in Vietnam [PDF]

open access: yesPLoS Medicine, 2014
Anna Lena Lopez et ses collègues donnent un aperçu de la situation du choléra au Vietnam et discutent de la façon dont un vaccin oral contre le choléra a été développé et utilisé dans le cadre d'une stratégie de santé publique contre la maladie.
Đặng Đức Anh   +8 more
openaire   +5 more sources

Vaccination strategies to combat an infectious globe: Oral cholera vaccines

open access: yesJournal of Global Infectious Diseases, 2011
Cholera is a substantial health burden in many countries in Africa and Asia, where it is endemic. It is as well responsible for ongoing epidemics in sub-Saharan Africa which are becoming greater in terms of frequency, extension, and duration.
Rosa M López-Gigosos   +3 more
doaj   +3 more sources

Stockpiling oral cholera vaccine

open access: yesBulletin of the World Health Organization, 2012
Cholera is re-emerging as a threat on the global public health stage. The number of reported cases worldwide is back at the peak level observed two decades ago,1 new Vibrio cholerae strains have appeared and antimicrobial resistance has increased. Weak surveillance systems and the possibility of travel and trade sanctions contribute to widespread ...
Stephen Martin   +2 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy